Concentric Capital Strategies’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-963
Closed -$261K – 429
2026
Q1
$261K Buy
+963
New +$287K 0.02% 287
2025
Q4
– Sell
-1,314
Closed -$454K – 399
2025
Q3
$454K Sell
1,314
-3,922
-75% -$1.19M 0.02% 268
2025
Q2
$1.63M Buy
+5,236
New +$2M 0.07% 200
2025
Q1
– Sell
-695
Closed -$352K – 304
2024
Q4
$352K Sell
695
-3,148
-82% -$1.79M 0.02% 236
2024
Q3
$2.25M Buy
3,843
+1,101
+40% +$623K 0.09% 183
2024
Q2
$1.4M Buy
+2,742
New +$1.34M 0.07% 229
2024
Q1
– Sell
-768
Closed -$404K – 371
2023
Q4
$404K Sell
768
-2,967
-79% -$1.58M 0.05% 177
2023
Q3
$1.88M Buy
+3,735
New +$1.84M 0.19% 109

Other funds holding UNH

Concentric Capital Strategies's UNH Position: Q2 2026 in Review

Concentric Capital Strategies sold out of UnitedHealth (UNH) in Q2 2026, closing a stake of 963 shares — an estimated $261K sold.

Concentric Capital Strategies first reported a position in UNH in Q3 2023 and held it in 8 quarters. The position peaked at $2.25M in Q3 2024. 3,394 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Concentric Capital Strategies reported no remaining UnitedHealth position as of Q2 2026 after selling out during the quarter.
  • Concentric Capital Strategies sold 963 UnitedHealth shares in Q2 2026, an estimated $261K.
  • Concentric Capital Strategies first reported a position in UnitedHealth in Q3 2023 and held it in 8 quarters.
  • Concentric Capital Strategies's UnitedHealth position peaked at $2.25M in Q3 2024.
  • 3,394 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.